1887

Abstract

Human papillomavirus type 16 (HPV16) has a number of intratypic variants; each has a different geographical distribution and some are associated with enhanced oncogenic potential. Cervical samples were collected from 223 cervical cancer patients and from 196 age-matched control subjects in China. DNA samples were amplified by using primers specific for the E6, E7 and partial L1 regions. Products were sequenced and analysed. It was found by using a PCR–sequence-based typing method that HPV infection rates in China were 92·8 % in cervical cancer patients and 15·8 % in healthy controls. HPV16 was detected in 70·4 % of cervical cancer patients and in 6·1 % of controls. In HPV16-positive cervical cancers, 23·6 % belonged to the prototype, 65·5 % were of the Asian variant, 5·5 % were of African type 1 and 3·6 % were European variants, whilst only one was a new variant that differed from any variant published so far. Prevalences of HPV16 E6 D25E and E113D variants were 67·3 and 9 %, respectively. In addition to D25E and E113D, the following E6 variations were found in this study: R129K, E89Q, S138C, H78Y, L83V and F69L. The results also showed that the prevalences of three hot spots of E7 nucleotide variation, N29S, S63F and a silent variation, nt T846C, were 70·2 % (33/47), 51·1 % (24/47) and 61·7 % (29/47), respectively. The following L1 variations were found in this study: S377A, K387E, E378D, K382E and T379P. It was also found that the average age of Asian variant-positive cervical cancer patients (42·98±10·43 years) was 7·56 years lower than that of prototype-positive patients (50·54±10·91). It is suggested that the high frequency of HPV16 Asian variants might contribute to the high incidence of cervical cancer in China.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81649-0
2006-05-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/5/1181.html?itemId=/content/journal/jgv/10.1099/vir.0.81649-0&mimeType=html&fmt=ahah

References

  1. Andersson S., Alemi M., Rylander E., Strand A., Larsson B., Sällström J., Wilander E. 2000; Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 83:307–310 [CrossRef]
    [Google Scholar]
  2. Baay M. F. D., Quint W. G. V., Koudstaal J., Hollema H., Duk J. M., Burger M. P. M., Stolz E., Herbrink P. 1996; Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34:745–747
    [Google Scholar]
  3. Berumen J., Ordoñez R. M., Lazcano E. & 7 other authors 2001; Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case–control study. J Natl Cancer Inst 93:1325–1330 [CrossRef]
    [Google Scholar]
  4. Bontkes H. J., van Duin M., de Gruijl T. D. & 11 other authors 1998; HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78:166–171 [CrossRef]
    [Google Scholar]
  5. Chan P. K. S., Lam C. W., Cheung T. H., Li W. W. H., Lo K. W. K., Chan M. Y. M., Cheung J. L. K., Xu L. Y., Cheng A. F. 2002; Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 186:696–700 [CrossRef]
    [Google Scholar]
  6. de Boer M. A., Peters L. A. W., Aziz M. F., Siregar B., Cornain S., Vrede M. A., Jordanova E. S., Kolkman-Uljee S., Fleuren G. J. 2004; Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94:488–494 [CrossRef]
    [Google Scholar]
  7. Ellis J. R. M., Keating P. J., Baird J. & 8 other authors 1995; The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1:464–470 [CrossRef]
    [Google Scholar]
  8. Eschle D., Dürst M., ter Meulen J., Luande J., Eberhardt H. C., Pawlita M., Gissmann L. 1992; Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol 73:1829–1832 [CrossRef]
    [Google Scholar]
  9. Etherington I. J., Ellis J. R., Luesley D. M., Moffitt D. D., Young L. S. 1999; Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol 72:56–59 [CrossRef]
    [Google Scholar]
  10. Fujinaga Y., Okazawa K., Nishikawa A., Yamakawa Y., Fukushima M., Kato I., Fujinaga K. 1994; Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 9:85–92 [CrossRef]
    [Google Scholar]
  11. Gravitt P. E., Burk R. D., Lorincz A. & 7 other authors 2003; A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 12:477–484
    [Google Scholar]
  12. Hildesheim A. 1997; Human papillomavirus variants: implications for natural history studies and vaccine development efforts. J Natl Cancer Inst 89:752–753 [CrossRef]
    [Google Scholar]
  13. Hildesheim A., Wang S. S. 2002; Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229–240 [CrossRef]
    [Google Scholar]
  14. Ho L., Chan S.-Y., Chow V., Chong T., Tay S.-K., Villa L. L., Bernard H.-U. 1991; Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29:1765–1772
    [Google Scholar]
  15. Hu X., Pang T., Guo Z., Mazurenko N., Kisseljov F., Pontén J., Nistér M. 2001; HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br J Cancer 84:791–795 [CrossRef]
    [Google Scholar]
  16. Kämmer C., Tommasino M., Syrjänen S., Delius H., Hebling U., Warthorst U., Pfister H., Zehbe I. 2002; Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 86:269–273 [CrossRef]
    [Google Scholar]
  17. Kang S., Jeon Y. T., Kim J. W., Park N. H., Song Y. S., Kang S. B., Lee H. P. 2005; Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int J Gynecol Cancer 15:107–112 [CrossRef]
    [Google Scholar]
  18. Lefevre J., Hankins C., Pourreaux K., Voyer H., Coutlée F. 2003; Real-time PCR assays using internal controls for quantitation of HPV-16 and β -globin DNA in cervicovaginal lavages. Canadian Women's HIV Study Group. J Virol Methods 114:135–144 [CrossRef]
    [Google Scholar]
  19. Liu J., Rose B., Huang X., Liao G., Carter J., Wu X., Thompson C. 2004; Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Gynecol Oncol 94:803–810 [CrossRef]
    [Google Scholar]
  20. Matsumoto K., Yasugi T., Nakagawa S., Okubo M., Hirata R., Maeda H., Yoshikawa H., Taketani Y. 2003; Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 106:919–922 [CrossRef]
    [Google Scholar]
  21. Muñoz N. 2000; Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5 [CrossRef]
    [Google Scholar]
  22. Nindl I., Rindfleisch K., Lotz B., Schneider A., Dürst M. 1999; Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82:203–207 [CrossRef]
    [Google Scholar]
  23. Parkin D. M., Pisani P., Ferlay J. 1999; Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827–841 [CrossRef]
    [Google Scholar]
  24. Radhakrishna Pillai M., Sreevidya S., Pollock B. H., Jayaprakash P. G., Herman B. 2002; Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol Oncol 87:268–273 [CrossRef]
    [Google Scholar]
  25. Seedorf K., Krämmer G., Dürst M., Suhai S., Röwekamp W. G. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185 [CrossRef]
    [Google Scholar]
  26. Song Y. S., Kee S. H., Kim J. W., Park N. H., Kang S. B., Chang W. H., Lee H. P. 1997; Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 66:275–281 [CrossRef]
    [Google Scholar]
  27. Stephen A. L., Thompson C. H., Tattersall M. H., Cossart Y. E., Rose B. R. 2000; Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 86:695–701 [CrossRef]
    [Google Scholar]
  28. Terry G., Ho L., Cuzick J. 1997; Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. Int J Cancer 73:651–655 [CrossRef]
    [Google Scholar]
  29. Villa L. L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., Franco E. L. 2000; Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959–2968
    [Google Scholar]
  30. Wu Y., Chen Y., Li Y., Yu G., Zhang Y., He Y. 2006a; Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35:264–269 [CrossRef]
    [Google Scholar]
  31. Wu Y., Chen Y., Li Y. & 8 other authors 2006b; Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer (in press). doi: 10.1002/ijc.21746
    [Google Scholar]
  32. Xi L. F., Demers G. W., Koutsky L. A., Kiviat N. B., Kuypers J., Watts D. H., Holmes K. K., Galloway D. A. 1995; Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172:747–755 [CrossRef]
    [Google Scholar]
  33. Yamada T., Wheeler C. M., Halpern A. L., Stewart A.-C. M., Hildesheim A., Jenison S. A. 1995; Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69:7743–7753
    [Google Scholar]
  34. Yamada T., Manos M. M., Peto J., Greer C. E., Muñoz N., Bosch F. X., Wheeler C. M. 1997; Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71:2463–2472
    [Google Scholar]
  35. Zehbe I., Wilander E., Delius H., Tommasino M. 1998; Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829–833
    [Google Scholar]
  36. Zehbe I., Tachezy R., Mytilineos J. & 7 other authors 2001; Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94:711–716 [CrossRef]
    [Google Scholar]
  37. Zehbe I., Mytilineos J., Wikström I., Henriksen R., Edler L., Tommasino M. 2003; Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol 64:538–542 [CrossRef]
    [Google Scholar]
  38. Zhang J. M. 1986; The distribution and characteristics of carcinoma of the cervix uteri in Lue Yang county. Zhonghua Liu Xing Bing Xue Za Zhi 7:343–345 (in Chinese
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81649-0
Loading
/content/journal/jgv/10.1099/vir.0.81649-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error